Showing results (5231-5240 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|September 15, 2019
Immune Check Point CD40-CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma CellsRegina M Hillebrand, Annabelle Vogt, Christian P Strassburg, et al.
Anticancer Research|September 15, 2019
Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory CancerShojiro Kikuchi, Kazuma Noguchi, Keiko Wakai, et al.
Anticancer Research|September 15, 2019
Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in MiceAkihiro Ito, Hayao Nakanishi, Mayumi Yoshimura, et al.
Anticancer Research|September 15, 2019
The Effects of Analgesics and Local Anesthetics on Gene Transcription Mediated by NFATc2 and Sp1 in Pancreatic CarcinomaManuela Malsy, Bernhard Graf, Anika Bundscherer
Anticancer Research|September 15, 2019
Inhibition of Tumor Growth and Sensitization to Sunitinib by RNA Interference Targeting Programmed Death-ligand 1 in Mouse Renal Cell Carcinoma RenCa ModelTakuto Hara, Hideaki Miyake, Nobuyuki Hinata, et al.
Anticancer Research|September 15, 2019
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse ModelTakashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Anticancer Research|September 15, 2019
Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer CellsHiroko Takagi, Hiromi Ii, Susumu Kageyama, et al.
Anticancer Research|September 15, 2019
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic CancerTomomi Sanomachi, Shuhei Suzuki, Keita Togashi, et al.
Anticancer Research|September 15, 2019
mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both In Vitro and In VivoHui-Fen Liao, You-Zhu Lin, Chih-Chia Yu, et al.
Anticancer Research|September 15, 2019
Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 CellsLuba Hunakova, Eva Horvathova, Paulina Gronesova, et al.
Pageof 2,589